D. E. Shaw & Co »

Bicara Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.5M 277k 19.89
2025-12-31 $2.3M 137k 16.83

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C Call Option (GOOG)
Micron Technology Put Option (MU)
Meta Platforms Cl A Call Option (META)
Amazon (AMZN)
Boston Scientific Corporation Call Option (BSX)
Advanced Micro Devices Put Option (AMD)
Taiwan Semiconductor Manufac Sponsored Ads Call Option (TSM)
JPMorgan Chase & Co. Call Option (JPM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for D. E. Shaw & Co

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Vestal Point Capital
Deep Track Capital
Henderson Group
Red Tree Management
Tpg Gp A
BlackRock
Omega Fund Management
FMR
Vanguard Capital Management
Citadel Advisors
Franklin Resources
State Street Corporation
T. Rowe Price Associates

View all funds holding Bicara Therapeutics